Q-Centrix CEO and leadership

Milton G. Silva-Craig is a successful leader who has demonstrated expertise in growing and scaling businesses in various fields of healthcare, including IT, medical imaging and quality data management, with 25 years of experience. He has been the Chief Executive Officer of Q-Centrix for the past five years, recently leading the company through a successful sale from private equity firm Sterling Partners to TPG Growth. Prior to Q-Centrix, he served as president of TransUnion’s healthcare business unit, where, he developed and executed a strategic business plan focused on repositioning and growing TransUnion in the healthcare marketplace, resulting in an eightfold increase.. Prior to TransUnion, Silva-Craig served as the President and Chief Operating Officer at Emageon Inc., leading the company’s strategic direction and operations. He grew revenues from several hundred thousand dollars to more than $100 million, and eventually led Emageon through its initial public offering on NASDAQ in 2005. He also held executive positions at General Electric Medical Systems. Silva-Craig earned a J.D. from the University of Wisconsin School of Law in Madison and obtained his M.B.A. and B.A. from the University of Wisconsin - Madison.

Jim Yamshak is a Chief Business Development Officer at Q-Centrix and is based in Birmingham, Alabama. He has worked as Senior Advisor at Foundation Radiology Group, Director of Sales at Emageon, and VP Sales East Region at Emageon. Jim attended Auburn University between 1987 and 1991.

Raghu Bukkapatnam is a Chief Growth Officer at Q-Centrix. He has experience at CHANGE HEALTHCARE INC.. Raghu attended University of Alabama at Birmingham and University of Washington.

Milton G. Silva-Craig is a successful leader who has demonstrated expertise in growing and scaling businesses in various fields of healthcare, including IT, medical imaging and quality data management, with 25 years of experience. He has been the Chief Executive Officer of Q-Centrix for the past five years, recently leading the company through a successful sale from private equity firm Sterling Partners to TPG Growth. Prior to Q-Centrix, he served as president of TransUnion’s healthcare business unit, where, he developed and executed a strategic business plan focused on repositioning and growing TransUnion in the healthcare marketplace, resulting in an eightfold increase.. Prior to TransUnion, Silva-Craig served as the President and Chief Operating Officer at Emageon Inc., leading the company’s strategic direction and operations. He grew revenues from several hundred thousand dollars to more than $100 million, and eventually led Emageon through its initial public offering on NASDAQ in 2005. He also held executive positions at General Electric Medical Systems. Silva-Craig earned a J.D. from the University of Wisconsin School of Law in Madison and obtained his M.B.A. and B.A. from the University of Wisconsin - Madison.